Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New paddle catheter aims to sharpen heart mapping

NCT ID NCT07116525

First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 44 times

Summary

This study is testing a new paddle-shaped catheter designed to map the heart's electrical signals in people with arrhythmias like atrial fibrillation or ventricular tachycardia. The goal is to see if it is safe and can create detailed maps to guide treatment. Sixty participants will undergo a standard mapping procedure using this investigational device.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AZ Sint-Jan

    RECRUITING

    Bruges, 8000, Belgium

  • CHU de Bordeaux - Hospital Haut-Leveque

    RECRUITING

    Pessac, 33600, France

  • Chu Rennes Hopital Pontchaillou

    RECRUITING

    Rennes, 35033, France

  • Hopital les Franciscaines of Nimes

    WITHDRAWN

    Nîmes, 30000, France

  • Jessa Ziekenhuis

    RECRUITING

    Hasselt, 3500, Belgium

  • Vilnius University Hospital Santaros Clinics

    RECRUITING

    Vilnius, 08406, Lithuania

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Paddle-shaped, high-density, multi-electrode mapping catheter

What this could lead to

If successful, this catheter could provide clearer heart maps for doctors treating arrhythmias, potentially improving ablation accuracy.

What could go wrong

This is an early feasibility study with only 60 participants. The catheter may not map as well as existing tools, and there is a risk of serious side effects like injury or hospitalization.

Conditions

The condition(s) this trial relates to.

atrial fibrillation cardiomyopathy Ventricular Premature Complexes ventricular tachycardia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.